Jump to content

Antisoma licensing partners for cancer drug


Recommended Posts

Antisoma says in talks with potential licensing partners for cancer drug

LONDON (AFX) - Cancer drug developer Antisoma PLC said it is in discussions with several potential licensing partners for its drug AS1404.

The firm said phase II (proof of concept) clinical trials are now fully recruited, and that final-phase trials in lung cancer are being prepared.

Chief executive Glyn Edwards said: 'There are few phase III oncology products available for licensing with strong data from controlled phase II studies, so it's not surprising that we've seen a high level of interest in AS1404.

'We are confident that we can secure a deal which reflects the advanced stage and blockbuster potential of this drug

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.